Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation-Reference-Cited by-同舟云学术

Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation

Author:

Kim Ho Shin¹,Hammill Jared T.¹,Scott Daniel C.²,Chen Yizhe¹,Min Jaeki³,Rector Jonah¹,Singh Bhuvanesh⁴,Schulman Brenda A.²⁵,Guy R. Kiplin¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40508, United States

2. Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

3. Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

4. Department of Surgery, Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York New York 10065, United States

5. Department of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried 82152, Germany

Funder

U.S. Department of Health and Human Services

St. Jude Children's Research Hospital

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

Reference46 articles.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. DCUN1D1 and neddylation: Potential targets for cancer therapy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10